Dr Tom Turner is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. He has completed a PhD in Neuroscience at University College London (UCL) Queen Square Institute of Neurology, working in the labs of Professor Dimitri Kullmann and Dr Gabriele Lignani. Tom's research was funded by the Medical Research Council and explored the use of CRISPR genome editing as a treatment for genetic neurological diseases. Previously, he studied Pharmacology at UCL, with research experience in cellular signalling mechanisms at the University of Cambridge's Department of Pharmacology.
Dr Tom Turner reviews a new book by medic and biotech entrepreneur Dr William Haseltine and science writer Dr Kim Hazel, who aim to summarise the gene therapy landscape for a lay audience...
A potential new gene target for Alzheimer's disease treatment has been identified using brain organoids...
Four stranded regions of the genome have been linked to chemotherapy resistance in ovarian cancer, offering a new potential avenue for therapy...
Genome editing has been used to disrupt a type of repetitive DNA sequence that is found in certain genes and can cause severe neurological disease...
Using CRISPR to edit a single gene in mice with head and neck cancer led to half of them becoming tumour-free...
A molecule that can be used to enhance CRISPR genome editing also causes unintended destruction of large sections of the genome in human cells...
UK BioBank, and potentially other organisations, will be able to access the GP data of consenting participants in England...
Award-winning and prolific science writer, Dr Philip Ball, offers a wide perspective in his latest book 'How Life Works'...
An Israeli strike on the largest fertility clinic in Gaza has destroyed thousands of embryos...
Using research from both social sciences and genetics literature as support, Ancestry Reimagined establishes realistic expectations about what we can learn from our DNA and the impact of an increased access to ancestry testing...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
